» Articles » PMID: 29968759

Identification of Pathways and Genes Associated with Synovitis in Osteoarthritis Using Bioinformatics Analyses

Overview
Journal Sci Rep
Specialty Science
Date 2018 Jul 4
PMID 29968759
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Synovitis in osteoarthritis (OA) is a very common condition. However, its underlying mechanism is still not well understood. This study aimed to explore the molecular mechanisms of synovitis in OA. The gene expression profile GSE82107 (downloaded from the Gene Expression Omnibus database) included 10 synovial tissues of the OA patients and 7 synovial tissues of healthy people. Subsequently, differentially expressed gene (DEG) analysis, GO (gene ontology) enrichment analysis, pathway analysis, pathway network analysis, and gene signal network analysis were performed using Gene-Cloud of Biotechnology Information (GCBI). A total of 1,941 DEGs consisting of 1,471 upregulated genes and 470 downregulated genes were determined. Genes such as PSMG3, LRP12 MIA-RAB4B, ETHE1, SFXN1, DAZAP1, RABEP2, and C9orf16 were significantly regulated in synovitis of OA. In particular, the MAPK signalling pathway, apoptosis, and pathways in cancer played the most important roles in the pathway network. The relationships between these pathways were also analysed. Genes such as NRAS, SPHK2, FOS, CXCR4, PLD1, GNAI2, and PLA2G4F were strongly implicated in synovitis of OA. In summary, this study indicated that several molecular mechanisms were implicated in the development and progression of synovitis in OA, thus improving our understanding of OA and offering molecular targets for future therapeutic advances.

Citing Articles

Exploration of the mechanism of tetramethoxyflavone in treating osteoarthritis based on network pharmacology and molecular docking.

Chen P, Ye B, Lin C, Zhang C, Chen J, Li L Tzu Chi Med J. 2025; 37(1):99-108.

PMID: 39850388 PMC: 11753527. DOI: 10.4103/tcmj.tcmj_77_24.


Analysis of key pathways and genes in nodal structure on rat skin surface using gene ontology and KEGG pathway.

Shin J, Park A, Ju S, Lee H, Kang H, Han D Genes Genomics. 2024; 47(1):71-85.

PMID: 39503930 DOI: 10.1007/s13258-024-01582-y.


SPHK2 Knockdown Inhibits the Proliferation and Migration of Fibroblast-Like Synoviocytes Through the IL-17 Signaling Pathway in Osteoarthritis.

Zheng J, Xiong X, Li K, Wang G, Cao H, Huang H J Inflamm Res. 2024; 17:7221-7234.

PMID: 39416266 PMC: 11479950. DOI: 10.2147/JIR.S476077.


Comprehensive analysis of PSMG3 in pan-cancer and validation of its role in hepatocellular carcinoma.

Zheng M, Chen X, Xu Z, Ye Z, Zhong L, Chen Z Clin Transl Oncol. 2024; 27(1):319-332.

PMID: 38967739 DOI: 10.1007/s12094-024-03580-8.


Hyaluronic-Acid-Nanomedicine Hydrogel for Enhanced Treatment of Rheumatoid Arthritis by Mediating Macrophage-Synovial Fibroblast Cross-Talk.

Wang Y, Wang J, Ma M, Gao R, Wu Y, Zhang C Biomater Res. 2024; 28:0046.

PMID: 38894889 PMC: 11185174. DOI: 10.34133/bmr.0046.


References
1.
ONeill T, Parkes M, Maricar N, Marjanovic E, Hodgson R, Gait A . Synovial tissue volume: a treatment target in knee osteoarthritis (OA). Ann Rheum Dis. 2015; 75(1):84-90. PMC: 4717397. DOI: 10.1136/annrheumdis-2014-206927. View

2.
Vrana K, Freeman W, Aschner M . Use of microarray technologies in toxicology research. Neurotoxicology. 2003; 24(3):321-32. DOI: 10.1016/S0161-813X(02)00193-6. View

3.
Yang Z, Xu S, Jin P, Yang X, Li X, Wan D . MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis. Oncotarget. 2016; 7(25):37649-37663. PMC: 5122339. DOI: 10.18632/oncotarget.8726. View

4.
Shi J, Wang E, Zuber J, Rappaport A, Taylor M, Johns C . The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia. Oncogene. 2012; 32(7):930-8. PMC: 4102143. DOI: 10.1038/onc.2012.110. View

5.
Luo Y, Wen X, Wang L, Gao J, Wang Z, Zhang C . Identification of MicroRNAs Involved in Growth Arrest and Apoptosis in Hydrogen Peroxide-Treated Human Hepatocellular Carcinoma Cell Line HepG2. Oxid Med Cell Longev. 2016; 2016:7530853. PMC: 5002491. DOI: 10.1155/2016/7530853. View